Tertiary Research Finding: Antioxidant Enzyme Induction Beyond direct hormonal control, Epithalon influences the antioxidant defence system. It has been observed to increase the activity of Superoxide Dismutase (SOD), Glutathione Peroxidase, and Catalase. Researchers use the 10mg pen to treat models of oxidative stress, measuring the reduction in lipid peroxidation markers (such as MDA). This suggests that Epithalon functions as a “geroprotector” by mitigating the accumulation of reactive oxygen species (ROS) damage over time.

Long-term Genomic and Safety Observations A critical area of Epithalon research is its safety profile regarding oncogenesis. While telomerase activation is a hallmark of cancer, studies indicate that Epithalon does not induce malignant transformation; rather, it suppresses spontaneous tumour development in ageing models. Genomic analysis utilising the 10mg dose monitors the expression of tumour suppressor genes (p16, p21) to verify that the extension of cellular lifespan occurs within a regulated, non-tumorigenic framework.